Graft protection by myeloid progenitor cells using lethal or non-lethal preconditioning

Area of Science:

• Immunology
• Transplantation Biology
• Cell Therapy

Background:

• Myeloid progenitor cell (MPC) therapy offers protection against infection and irradiation.
• However, MPC therapy can also prevent the rejection of matched grafts.
• Understanding the matching requirements for MPCs in graft protection is crucial.

Purpose of the Study:

• To investigate the matching requirements between myeloid progenitor cells (MPCs) and skin grafts.
• To develop a non-lethal preconditioning model for MPC-induced skin graft protection.
• To assess MPC efficacy in a trachea transplant model.

Main Methods:

• Mouse MPCs (mMPCs) were expanded ex vivo from HSCs.
• Skin grafts were tested in mice undergoing lethal irradiation and reconstitution with allogeneic mMPCs and HSCs.
• An alternative model used non-lethal preconditioning with depleting antibodies and chemotherapeutics before mMPC transplantation without HSCs.

Main Results:

• Closely matched mMPC grafts were protected, with no significant difference between fully matched and partially matched grafts under irradiation.
• Haploidentical grafts (half MHC alleles unmatched) were not protected.
• MPC-mediated graft protection was effective in a trachea transplant model and did not require lethal preconditioning or HSC co-transplantation.

Conclusions:

• Closely matched myeloid progenitor cells are sufficient to prevent graft rejection.
• MPC therapy can protect grafts effectively in non-lethal preconditioning models.
• Graft protection mediated by MPCs influences both T-cell and B-cell responses.